Open menu
Paytm Money logo
search-placeholder
search
Mutual Fund Details
search-placeholder
search
Nippon India Mutual Fund

Nippon India Pharma Fund Direct-Growth

NAV
returns change indicator
285.0071
as on 01 Jul 2022, 11:20 PM
2.3602(0.84%)
Last Change
loaderloader

Investment Performance

would have given a return of
1,10,871
star
1,21,647
star
1,83,814
star
1,88,830
star
Bank Account
Fixed Deposit
Regular Mutual Fund
This Fund on Paytm Money
This Mutual Fund
88,830
Profit (absolute return)
88.83%
in the last
1m
3m
1y
3y
5y
max
+1% Higher Returns
With Direct Plans on Paytm Money

Investment Returns

In the last 3 months
9.91%
In the last 6 months
16.48%
In the last 1 year
13.81%
In the last 3 years
88.83%
In the last 5 years
112.12%
In the last 10 years
NA
Absolute Returns
CAGR

Scheme Riskometer

low
low
low to moderate
low to moderate
moderate
moderate
moderately high
moderately high
high
high
very high
very high
indicator
Investors understand that their principal will be at high risk

Scheme Information

Nippon India Pharma Fund Direct-Growth
Nippon India Pharma Fund Direct-Growth
as of 31 May 2022, 05:30 AM
4,515.92 Cr
Scheme Asset Size
Fund Type
Open-End
Exit Load
Exit load of 1% if redeemed within 1 month.
1.04%
Expense Ratio
Plan
Growth
1.66%
Cash Holding
Benchmark
S&P BSE Healthcare Total Return Index
Scheme Document
Benchmark
S&P BSE Healthcare Total Return Index
Exit Load
Exit load of 1% if redeemed within 1 month.
Scheme Document

Sectors Holding in this Mutual Fund

as on 31 May 2022
Sort By
Healthcare
98.33%
4,440.51 Cr
Cash Holding
1.66%
74.96 Cr
Others
0.01%
45.16 Lakh

Companies Holding in this Mutual Fund

as on 31 May 2022
Sort By
Sun Pharmaceutical Industries Ltd.
13.91%
628.16 Cr
Cipla Ltd.
9.23%
416.82 Cr
Dr. Reddy's Laboratories Ltd.
7.74%
349.53 Cr
Divi's Laboratories Ltd.
6.89%
311.15 Cr
Torrent Pharmaceuticals Ltd.
6.63%
299.41 Cr
Others
55.60%
2,510.85 Cr
View All
View All

About Nippon India Pharma Fund Direct-Growth

Nippon India Pharma Fund Direct-Growth is a Equity mutual fund scheme from Nippon India Mutual Fund. This scheme was launched on Invalid date and is currently managed by its fund manager Sailesh Raj Bhan. It has an AUM of ₹4,515.92 Crores and the latest NAV decalared is ₹285.007 as on 02 Jul 2022 at 4:17 am.
Nippon India Pharma Fund Direct-Growth scheme return performance in last 1 year is -13.81%, in last 3 years is 88.83% and 307.94% since scheme launch. The min. SIP amount to invest in this scheme is ₹100.

Scheme Details

AUM:4,515.92 Cr
Category:Equity: Sectoral-Pharma
Launch Date:Invalid date
Fund Type:Open-End

AMC Information

Nippon India Mutual Fund
Nippon India Mutual Fund
View AMC Details
2,77,359.28 Cr
AUM
221
Schemes